0

    542248

    DECCAN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Deccan Health Care Limited Share Price Today

    Investment Returns

    Over 1 Month 5.52% Over 3 Months 19.35% Over 6 Months -3.11% Over 1 Year -35.29%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Deccan Health Care Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 33.10
    • P/E Ratio (TTM) 14.39
    • Beta 0.93
    • Book Value / share 44.53
    • Return on equity 1.18%
    • EPS (TTM) 0.93
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.23
    info icon alternate text

    Deccan Health Care Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 20.26
    Operating Expense 20.01
    Net Profit 0.23
    Net Profit Margin (%) 1.13
    Earnings Per Share (EPS) 0.09
    EBITDA 0.77
    Effective Tax Rate (%) 8.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 23.03
    Operating Expense 21.74
    Net Profit 0.95
    Net Profit Margin (%) 4.12
    Earnings Per Share (EPS) 0.38
    EBITDA 1.68
    Effective Tax Rate (%) 26.35
    Particulars SEP 2025 (Values in Cr)
    Revenue 24.40
    Operating Expense 23.18
    Net Profit 0.90
    Net Profit Margin (%) 3.68
    Earnings Per Share (EPS) 0.36
    EBITDA 1.71
    Effective Tax Rate (%) 26.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 21.47
    Operating Expense 21.18
    Net Profit 0.21
    Net Profit Margin (%) 0.97
    Earnings Per Share (EPS) 0.09
    EBITDA 0.73
    Effective Tax Rate (%) 30.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 20.82
    Operating Expense 20.58
    Net Profit 0.14
    Net Profit Margin (%) 0.67
    Earnings Per Share (EPS) 0.06
    EBITDA 0.63
    Effective Tax Rate (%) 44.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 89.17
    Operating Expense 86.13
    Net Profit 2.29
    Net Profit Margin (%) 2.56
    Earnings Per Share (EPS) 0.93
    EBITDA 4.89
    Effective Tax Rate (%) 25.16
    Particulars MAR 2025 (Values in Cr)
    Revenue 75.13
    Operating Expense 73.46
    Net Profit 1.20
    Net Profit Margin (%) 1.59
    Earnings Per Share (EPS) 0.56
    EBITDA 3.19
    Effective Tax Rate (%) 28.14
    Particulars MAR 2024 (Values in Cr)
    Revenue 59.73
    Operating Expense 57.50
    Net Profit 1.52
    Net Profit Margin (%) 2.54
    Earnings Per Share (EPS) 0.82
    EBITDA 3.77
    Effective Tax Rate (%) 32.14
    Particulars MAR 2023 (Values in Cr)
    Revenue 45.02
    Operating Expense 44.50
    Net Profit 0.40
    Net Profit Margin (%) 0.88
    Earnings Per Share (EPS) 0.24
    EBITDA 2.07
    Effective Tax Rate (%) 24.52
    Particulars MAR 2022 (Values in Cr)
    Revenue 33.17
    Operating Expense 29.45
    Net Profit 0.32
    Net Profit Margin (%) 0.96
    Earnings Per Share (EPS) 0.21
    EBITDA 2.16
    Effective Tax Rate (%) 40.74
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 44.94
    ROE % 1.14
    ROCE % 1.64
    Total Debt to Total Equity 0.01
    EBITDA Margin 4.20
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 46.90
    ROE % 1.67
    ROCE % 2.52
    Total Debt to Total Equity 0.02
    EBITDA Margin 6.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 47.86
    ROE % 0.39
    ROCE % 0.68
    Total Debt to Total Equity 0.02
    EBITDA Margin 4.40
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 48.97
    ROE % 3.00
    ROCE % 5.60
    Total Debt to Total Equity 0.01
    EBITDA Margin 17.65
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 48.76
    ROE % 0.51
    ROCE % 0.81
    Total Debt to Total Equity 0.01
    EBITDA Margin 6.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 45.01
    ROE % 1.18
    ROCE % 1.69
    Total Debt to Total Equity 0.01
    EBITDA Margin 4.25
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 46.96
    ROE % 1.70
    ROCE % 2.53
    Total Debt to Total Equity 0.02
    EBITDA Margin 6.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 47.91
    ROE % 0.50
    ROCE % 0.79
    Total Debt to Total Equity 0.02
    EBITDA Margin 4.60
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 48.97
    ROE % 3.00
    ROCE % 5.60
    Total Debt to Total Equity 0.01
    EBITDA Margin 17.64
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 48.76
    ROE % 0.51
    ROCE % 0.81
    Total Debt to Total Equity 0.02
    EBITDA Margin 6.22
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.55
    Total Assets 124.92
    Total Liabilities 124.92
    Total Equity 106.39
    Share Outstanding 2
    Price to Book Ratio 0.38
    Return on Assets (%) 0.92
    Return on Capital (%) 1.08
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.60
    Total Assets 108.04
    Total Liabilities 108.04
    Total Equity 96.91
    Share Outstanding 2
    Price to Book Ratio 0.59
    Return on Assets (%) 1.38
    Return on Capital (%) 1.51
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.41
    Total Assets 96.78
    Total Liabilities 96.78
    Total Equity 81.56
    Share Outstanding 1
    Price to Book Ratio 0.57
    Return on Assets (%) 0.31
    Return on Capital (%) 0.37
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.66
    Total Assets 90.62
    Total Liabilities 90.62
    Total Equity 76.94
    Share Outstanding 1
    Price to Book Ratio 0.73
    Return on Assets (%) 0.35
    Return on Capital (%) 0.41
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.22
    Total Assets 92.26
    Total Liabilities 92.26
    Total Equity 76.62
    Share Outstanding 1
    Price to Book Ratio 0.60
    Return on Assets (%) 0.42
    Return on Capital (%) 0.5
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.48
    Total Assets 123.93
    Total Liabilities 123.93
    Total Equity 106.55
    Share Outstanding 2
    Price to Book Ratio 0.38
    Return on Assets (%) 0.96
    Return on Capital (%) 1.11
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.22
    Total Assets 107.32
    Total Liabilities 107.32
    Total Equity 97.03
    Share Outstanding 2
    Price to Book Ratio 0.59
    Return on Assets (%) 1.41
    Return on Capital (%) 1.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.36
    Total Assets 96.47
    Total Liabilities 96.47
    Total Equity 81.65
    Share Outstanding 1
    Price to Book Ratio 0.57
    Return on Assets (%) 0.41
    Return on Capital (%) 0.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.65
    Total Assets 90.62
    Total Liabilities 90.62
    Total Equity 76.94
    Share Outstanding 1
    Price to Book Ratio 0.73
    Return on Assets (%) 0.35
    Return on Capital (%) 0.42
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.21
    Total Assets 92.26
    Total Liabilities 92.26
    Total Equity 76.62
    Share Outstanding 1
    Price to Book Ratio 0.60
    Return on Assets (%) 0.42
    Return on Capital (%) 0.5
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.63
    Cash from Operations -6.41
    Cash from Investing -0.13
    Cash from Financing 7.51
    Net change in Cash 0.95
    Free Cash Flow -6.27
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.21
    Cash from Operations -11.69
    Cash from Investing -0.29
    Cash from Financing 14.04
    Net change in Cash 1.19
    Free Cash Flow -11.38
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.43
    Cash from Operations -6.54
    Cash from Investing 0.27
    Cash from Financing 5.26
    Net change in Cash -1.23
    Free Cash Flow -6.54
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.94
    Cash from Operations -0.32
    Cash from Investing -0.04
    Cash from Financing 0.06
    Net change in Cash -0.55
    Free Cash Flow -0.20
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.51
    Cash from Operations 0.35
    Cash from Investing -0.07
    Cash from Financing -0.37
    Net change in Cash -0.22
    Free Cash Flow 0.45
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.66
    Cash from Operations -6.59
    Cash from Investing -0.13
    Cash from Financing 8.00
    Net change in Cash 1.26
    Free Cash Flow -6.45
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.24
    Cash from Operations -12.47
    Cash from Investing -0.29
    Cash from Financing 13.64
    Net change in Cash 0.86
    Free Cash Flow -12.16
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.53
    Cash from Operations -6.37
    Cash from Investing 0.26
    Cash from Financing 5.05
    Net change in Cash -1.27
    Free Cash Flow -6.37
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.94
    Cash from Operations -0.32
    Cash from Investing -0.04
    Cash from Financing 0.06
    Net change in Cash -0.55
    Free Cash Flow -0.20
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.51
    Cash from Operations 0.35
    Cash from Investing -0.08
    Cash from Financing -0.37
    Net change in Cash -0.23
    Free Cash Flow 0.44
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 64.99 13.42 127127.92 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 51.48 23.29 2.81 96.48 40.75 76.00
    SHREE PACETRONIX LTD. 152.05 18.14 3.20 57.01 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.08 0.00 2.78 23.34 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 84.68 12.75 127127.92 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.61 0.00 -9.39 28.84 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 5981.10 26.77 4.95 6543.32 5010.00 6725.00

    Deccan Health Care Limited shareholding pattern

    Holding
    74.86%
    19.46%
    5.67%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Deccan Health Care Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    13.38 0.60 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 13.20
    • 26 Days 12.90
    • 10 Days 0.00
    • 50 Days 12.70
    • 12 Days 13.10
    • 100 Days 13.00
    • 20 Days 13.00
    • 200 Days 14.60
    12.95 PIVOT
    First Support 12.51 First Resistance 13.75 Second Support 11.71 Second Resistance 14.19 Third Support 11.27 Third Resistance 14.99
    RSI 55.00 ADX 18.63 MACD 0.16 Williams % R -25.61 Commodity Channel Index (CCI) 92.31
    Date 2026-07-10 Week 4992.00 Same Day 7719.00 Month 6429.00
    1 Year 0.94 3 Year 0.92
    Over 1 Month
    5.52% down
    Over 1 Year
    -35.29% down
    Over 3 Months
    19.35% down
    Over 3 Years
    -21.35% down
    Over 6 Months
    -3.11% down
    Over 5 Years
    -16.00% down

    Deccan Health Care Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Deccan Health Care Ltd?

    Answer Field

    Deccan Health Care Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 13.38 as on Jul 10 2026 03:29 PM.

    What is the Market Cap of Deccan Health Care Ltd Share?

    Answer Field

    The market cap of Deccan Health Care Ltd for NSE ₹ 0.00 & for BSE ₹ 33.10 as on Jul 10 2026 03:29 PM.

    What is the 52 Week High and Low of Deccan Health Care Ltd?

    Answer Field

    The 52 Week High and Low of Deccan Health Care Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 22.99 and ₹ 6.65.

    What is 1 year return for Deccan Health Care Ltd?

    Answer Field

    The 1 year returns on the stock has been -35.29%.

    What is the P/E Ratio of Deccan Health Care Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM the price-to-earnings (PE) ratio for Deccan Health Care Ltd share is 14.39.

    What is the PB ratio of Deccan Health Care Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM, the price-to-book (PB) ratio for Deccan Health Care Ltd share is 44.53.

    How to Buy Deccan Health Care Ltd Share?

    Answer Field

    You can trade in Deccan Health Care Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Deccan Health Care Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Deccan Health Care Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Deccan Health Care Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |